1. WHO (World Health Organization). Noncommunicable Disease.

Noncommunicable Dis
Ctry Profiles. 2018;
2. WHO. 2016. Fact Sheet on Cardiovascular Disease. Online (at. http://who.int/) diakses
tanggal 30 Oktober 2016
3. Kementerian Kesehatan RI. Laporan Hasil Riset Kesehatan Dasar (Riskesdas) Indonesia
tahun 2018. Riset Kesehatan Dasar 2018. 2018. p. 182–3.
4. Ma WQ, Wang Y, Han XQ, Zhu Y, Liu NF. Association of genetic polymorphisms in
vascular endothelial growth factor with susceptibility to coronary artery disease: A meta-
analysis. BMC Med Genet. 2018;19(1):1–12.
5. Metzger CS, Koutsimpelas D, Brieger J. Transcriptional regulation of the VEGF gene in
dependence of individual genomic variations. Cytokine [Internet]. 2015;76(2):519–26.
Available from: http://dx.doi.org/10.1016/j.cyto.2015.07.015
6. KIM YR, HONG S-H. Association between the polymorphisms of the vascular
endothelial growth factor gene and metabolic syndrome. Biomed Reports.
2015;3(3):319–26.
7. Inoue, M., Itoh, H., Ueda, M., Naruko, T., Kojima, A., Komatsu, R., Doi, K., Ogawa, Y.,
Tamura, N., Takaya, K., Igaki, T., Yamashita, J., Chun, T. H., Masatsugu, K., Becker, A.
E., & Nakao, K. (1998). Vascular endothelial growth factor (VEGF) expression in human
coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in
progression of atherosclerosis. Circulation, 98(20), 2108–2116.
https://doi.org/10.1161/01.CIR.98.20.2108
8. Panutsopulos, D., Papalambros, E., Sigala, F., Zafiropoulos, A., Arvanitis, D. L., &
Spandidos, D. A. (2005). Protein and mRNA expression levels of VEGF-A and TGF-
beta1 in different types of human coronary atherosclerotic lesions. International Journal
of Molecular Medicine, 15(4), 603–610. https://doi.org/10.3892/ijmm.15.4.603
9. Amoli, M. M., Amiri, P., Alborzi, A., Larijani, B., Saba, S., & Tavakkoly-Bazzaz, J.
(2012). VEGF gene mRNA expression in patients with coronary artery disease.
Molecular Biology Reports, 39(9), 8595–8599. https://doi.org/10.1007/s11033-012-1713-
x
10. Anwari AF. Identifikasi Polimorfisme Gen Vegf-A (Rs2010963) Pada Turunan Pertama
Penderita Penyakit Jantung Koroner (Pjk) Dan Non-Pjk Di Kota Bengkulu. Skripsi.
Tidak diterbitkan, Fakultas Kedokteran Universitas Bengkulu: Bengkulu

11. B Pratama, A., Susianti, & I, W. (2014). Noni Fruits (Morinda citrifolia) as
Atherosclerosis Inhibitor. J Majority, 3(3), 18–26.
https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/215

12. Bergheanu, S. C., Bodde, M. C., & Jukema, J. W. (2017). Pathophysiology and treatment
of atherosclerosis: Current view and future perspective on lipoprotein modification
treatment. Netherlands Heart Journal, 25(4), 231–242. https://doi.org/10.1007/s12471-
017-0959-2
13. Anwar S, Enikarmila A, Zulkifli M, Ismawati. (2014). Histopatologi Arteri Koroner
Rattus novergicus Strain Wistar Jantan Pada Minggu Ke-12 Setelah Pemberian Diet
Aterogenik. JOM FK Volume 1 No. 2.
14. Sianturi, E. T., dan Evi, K. (2019). Pengaruh pektin terhadap penurunan resiko penyakit
jantung koroner. Majority, 8(1), 162–167.
15. WHO. The top 10 causes of death [internet]. Geneva: World Health Organization; 2018.
Tersedia dari: https://www.who.int/en/newsroom/fact-sheets/detail/the-top-10- causes-of-
death
16. Shahjehan RD, Bhutta BS. Coronary Artery Disease. [Updated 2021 Aug 7]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available
from: https://www.ncbi.nlm.nih.gov/books/NBK564304/
17. Olvera Lopez E, Ballard BD, Jan A. Cardiovascular Disease. [Updated 2021 Aug 11]. In:
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available
from: https://www.ncbi.nlm.nih.gov/books/NBK535419/
18. Purba JS, Misbach J. 2011. Biomolekuler stroke. Dalam : Misbach J. Stroke aspek
diagnosis, patofisiologi, manajemen. Badan Penerbit FKUI. Jakarta. hal: 41-52.
19. Kim OJ, Hong SH, Oh SH et al. 2011. Association between VEGF polymorphisms and
homocysteine levels in patients with ischemic stroke
20. Wang, Y., Huang, Q., Liu, J., Wang, Y., Zheng, G., Lin, L., Yu, H., Tang, W., & Huang,
Z. (2017). Vascular endothelial growth factor A polymorphisms are associated with
 increased risk of coronary heart disease: A meta-analysis. Oncotarget, 8(18), 30539–
30551.
21. Mo, Y., Wan, R., & Zhang, Q. (2012). Application of reverse transcription-PCR and real-
time PCR in nanotoxicity research. Methods in molecular biology (Clifton, N.J.), 926,
99–112. https://doi.org/10.1007/978-1-62703-002-1_7
22. Daniel H. Farkas, Carol A. Holland, Chapter 3 - Overview of Molecular Diagnostic
Techniques and Instrumentation, Editor(s): Raymond R. Tubbs, Mark H. Stoler, Cell and
Tissue Based Molecular Pathology, Churchill Livingstone, 2009, Pages 19-32, ISBN
9780443069017, https://doi.org/10.1016/B978-044306901-7.50008-0
23. Doak, S. H., & Zaïr, Z. M. (2012). Real-time reverse-transcription polymerase chain
reaction: Technical considerations for gene expression analysis. Methods in Molecular
Biology, 817, 251–270. https://doi.org/10.1007/978-1-61779-421-6_13
24. Hewajuli, D. A., & Dharmayanti, N. (2014). The Advance of Technology of Reverse Transcriptase-
Polymerase Chain Reaction in Identifying the Genome of Avian Influenza and Newcastle
Diseases. Indonesian Bulletin of Animal and Veterinary Sciences, 24(1), 16–29.
https://doi.org/10.14334/wartazoa.v24i1.1022